Abstract
Background
Although previous case-control studies have observed positive associations among gonorrhea, syphilis, clinical prostatitis, and prostate cancer, many may have been susceptible to recall and interviewer biases due to their retrospective designs. Therefore, to investigate these associations without concerns of recall and interviewer biases, we conducted a large, prospective investigation in the Health Professionals Follow-up Study.Methods
In 1992, participants were asked to report their histories of gonorrhea, syphilis, and clinical prostatitis by mailed questionnaire. Prostate cancer diagnoses were ascertained by self-report on the 1994 and each subsequent biennial follow-up questionnaire and confirmed by medical record review.Results
Of the 36,033 participants in this analysis, 2,263 were diagnosed with prostate cancer between the date of return of the 1992 questionnaire and 2002. No association was observed between gonorrhea [adjusted relative risk (RR), 1.04; 95% confidence interval (95% CI), 0.79-1.36] or syphilis (RR, 1.06; 95% CI, 0.44-2.59) and prostate cancer. Overall null results were also observed between clinical prostatitis and prostate cancer (RR, 1.08; 95% CI, 0.96-1.20), although a significant positive association was observed among younger men (<59 years) screened for prostate cancer (RR, 1.49; 95% CI, 1.08-2.06; P(interaction) = 0.006).Conclusions
Gonorrhea and syphilis do not seem to be risk factors for prostate cancer in this cohort of men with a lower burden of sexually transmitted infections. Clinical prostatitis is also unlikely to be a risk factor, although possible roles for prostatitis in younger men and asymptomatic prostatic infection and inflammation cannot be ruled out.Citations & impact
Impact metrics
Citations of article over time
Article citations
Sexually and non-sexually transmitted infections and the risk of prostate cancer: Results from the EPICAP study.
Cancer Med, 13(1):e6841, 04 Jan 2024
Cited by: 1 article | PMID: 38174802 | PMCID: PMC10807638
Role of IL-17A and IL-17RA in Prostate Cancer with Lymph Nodes Metastasis: Expression Patterns and Clinical Significance.
Cancers (Basel), 15(18):4578, 15 Sep 2023
Cited by: 0 articles | PMID: 37760548 | PMCID: PMC10526823
Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2.
Cancers (Basel), 15(3):630, 19 Jan 2023
Cited by: 2 articles | PMID: 36765589 | PMCID: PMC9913270
Induction of apoptosis by essential oil of Dracocephalum kotschyi on Trichomonas vaginalis.
Vet Med Sci, 9(2):1008-1016, 17 Oct 2022
Cited by: 2 articles | PMID: 36253818 | PMCID: PMC10029889
Inflammation and Prostate Cancer: A Multidisciplinary Approach to Identifying Opportunities for Treatment and Prevention.
Cancers (Basel), 14(6):1367, 08 Mar 2022
Cited by: 11 articles | PMID: 35326519 | PMCID: PMC8946208
Review Free full text in Europe PMC
Go to all (51) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.
J Urol, 176(3):1108-1113, 01 Sep 2006
Cited by: 52 articles | PMID: 16890703
Prostatitis as a risk factor for prostate cancer.
Epidemiology, 15(1):93-99, 01 Jan 2004
Cited by: 76 articles | PMID: 14712152
Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study.
Cancer Res, 63(23):8542-8548, 01 Dec 2003
Cited by: 37 articles | PMID: 14679023
Inflammation in the etiology of prostate cancer: an epidemiologic perspective.
Urol Oncol, 25(3):242-249, 01 May 2007
Cited by: 38 articles | PMID: 17483023
Review
Funding
Funders who supported this work.
NCI NIH HHS (2)
Grant ID: CA55075
Grant ID: P50CA58236
NHLBI NIH HHS (1)
Grant ID: HL35464